Welcome

Germany donates over 100 million vaccine doses in 2021

A truck with the German and European Flag and the word COVAX on its front

Distribution of vaccine doses in Vietnam via COVAX, © German Embassy Hanoi

19.11.2021 - Article

Germany is working to ensure fair global distribution of vaccines and has donated or contractually guaranteed over 100 million doses.

2.2 billion euro for vaccines, diagnostic tools and medicines

The pandemic can only be overcome if it is brought under control all over the world. Germany thus opted early on to focus on finding joint responses in a spirit of solidarity to the pandemic that continues to rage worldwide. Last year, Germany helped found the coordination mechanism Access to COVID-19 Tools Accelerator (ACT-Accelerator). With contributions totalling 2.2 billion euro to date, Germany is currently the mechanism’s second-largest donor. Most of this support is going to the international vaccine platform COVAX, while some is being used for diagnostic tools and medication to treat COVID-19. COVAX has already sent a total of more than 535 million doses of the AstraZeneca, Johnson & Johnson, Moderna and BioNTech vaccines, among others, to 144 states and territories as of mid-November. One hundred million euro of the German funding is earmarked for what is known as the humanitarian buffer, to supply vaccines for people such as refugees who are not covered by national vaccination plans.

Germany donates over 100 million vaccine doses in 2021

Since the end of August, the German Government has also been donating doses from its own stocks that are not needed for its national vaccination campaign, including booster shots. Germany will provide at least 175 million doses in total to industrialising and developing countries, with most of these vaccines being made available through COVAX. The German contribution is the second-highest worldwide and will help ensure better access to vaccines.

About 95 million doses have now been donated or guaranteed to COVAX and are gradually being distributed. By end of November  12,4 million of these doses had been passed on to 21 recipient countries, while around 82 million more are currently being distributed or prepared for dispatch.

COVAX has so far provided vaccines from German supply agreements to Mauritania, Ethiopia, Malawi, Togo, Tajikistan, the Sudan, Uzbekistan, Vietnam, Botswana, Egypt, the Islamic Republic of Iran, Jamaica, Nigeria, the Philippines, Kenya, Bangladesh, Côte d’Ivoire, Somalia, Pakistan, Guineaand Ghana. More substantial deliveries are to follow to Egypt, Togo, and Pakistan in the upcoming days and weeks.

The German Government has also donated around 7.7 million doses via bilateral channels to countries including Namibia, Egypt, Ukraine, Vietnam, Ghana and Thailand.

The EU plans to donate at least 500 million doses, and the US has provided approximately 252 million doses so far. The G7 intends to supply a total of at least 870 million doses by the end of 2022. The majority of these donations are to be given to COVAX, which knows conditions in the recipient countries best and can therefore distribute the vaccines fairly around the world. COVAX is currently supplying the AstraZeneca, Johnson & Johnson, Moderna and BioNTech vaccines, among others.

Multilateral solutions instead of vaccine nationalism

Germany and the EU are committed to finding a multilateral response to the pandemic and to ensuring fair, transparent and affordable access to COVID-19 vaccines, medicines and diagnostics around the globe. Ensuring that this access is not tied to political conditions is a joint approach in a spirit of solidarity which stands in contrast to the bilateral pledges and vaccine nationalism of some states. However, donations and financial support alone are not enough. Germany and the EU are therefore actively working to promote the production of vaccines in Africa in particular. Germany wants to secure regional healthcare in the long term and will provide funding to help set up vaccine production in countries including South Africa and Senegal.

The COVAX Manufacturing Taskforce was established in order to increase the supply and production of vaccines. The aim is specifically to raise the number of doses which can be produced at short notice and to prioritise these doses for COVAX. The 92 poorest countries are the particular focus of attention. In addition, vaccine production in the global South is to be expanded. Germany and South Africa are the co-chairs of the Taskforce and have submitted a report on this issue to the G20.

It will also remain a priority to distribute not only vaccines but medicines and testing materials. Healthcare systems weakened by COVID-19 must be strengthened for the future. The ACT-Accelerator is playing a valuable part in these efforts, too.

Germany is engaged – worldwide

Germany is helping with more than just vaccines. It also receives requests for ventilators, masks and medical equipment from all over the world. Germany has provided support to around 100 countries and has launched three major relief packages. Among other things, over 2500 ventilators have been donated. Furthermore, Germany has made available 450 million euro for humanitarian assistance in the context of COVID-19 in order to help people in humanitarian emergencies.

With a view to learning from the pandemic and boosting global pandemic resilience in the future, Germany is also calling for the global health architecture with the WHO at its heart to be strengthened. A special WHO session in late November will discuss measures to this end, including the idea of an international pandemic treaty.

For more information:

ACT Accelerator

COVAX Facility

Keywords

Top of page